|
2012-09-06 |
2012-09-05 |
K
Kauf
|
SPECTRUM PHARMACEUTICALS INC
Large shareholder
|
130.854.840
+100.0%
1,82
238.155.809 USD
|
130.854.840
+100.0%
|
1,82
|
238.155.809 USD
|
|
|
2012-03-01 |
2012-03-01 |
GV
Geplanter Verkauf
|
BENNETT BRUCE K JR
VP, Pharmaceutical Operations
Führungsperson
|
3.025
-2.0%
1,50
4.522 USD
|
3.025
-2.0%
|
1,50
|
4.522 USD
|
|
|
2012-03-01 |
2012-02-29 |
GV
Geplanter Verkauf
|
BENNETT BRUCE K JR
VP, Pharmaceutical Operations
Führungsperson
|
3.031
-2.0%
1,53
4.623 USD
|
3.031
-2.0%
|
1,53
|
4.623 USD
|
|
|
2012-02-27 |
2012-02-24 |
GV
Geplanter Verkauf
|
BENNETT BRUCE K JR
VP, Pharmaceutical Operations
Führungsperson
|
1.469
-1.3%
1,55
2.277 USD
|
1.469
-1.3%
|
1,55
|
2.277 USD
|
|
|
2011-02-25 |
2011-02-24 |
GV
Geplanter Verkauf
|
BENNETT BRUCE K JR
VP, Pharmaceutical Operations
Führungsperson
|
1.469
-1.5%
3,20
4.701 USD
|
1.469
-1.5%
|
3,20
|
4.701 USD
|
|
|
2010-05-12 |
2010-05-10 |
GV
Geplanter Verkauf
|
Clark David C
VP, Finance
Führungsperson
|
3.085
-15.3%
7,03
21.684 USD
|
3.085
-15.3%
|
7,03
|
21.684 USD
|
|
|
2010-04-14 |
2010-04-12 |
GV
Geplanter Verkauf
|
Graboyes Marc H
SVP, General Counsel
Führungsperson
|
75.000
-56.4%
8,58
643.530 USD
|
75.000
-56.4%
|
8,58
|
643.530 USD
|
|
|
2010-03-12 |
2010-03-10 |
GV
Geplanter Verkauf
|
Clark David C
VP, Finance
Führungsperson
|
20.000
-50.8%
7,78
155.612 USD
|
20.000
-50.8%
|
7,78
|
155.612 USD
|
|
|
2010-03-08 |
2010-03-05 |
GV
Geplanter Verkauf
|
Clark David C
VP, Finance
Führungsperson
|
10.000
-34.1%
7,02
70.196 USD
|
10.000
-34.1%
|
7,02
|
70.196 USD
|
|
|
2010-03-08 |
2010-03-04 |
GV
Geplanter Verkauf
|
Clark David C
VP, Finance
Führungsperson
|
11.640
-37.6%
6,98
81.301 USD
|
11.640
-37.6%
|
6,98
|
81.301 USD
|
|
|
2010-03-03 |
2010-03-01 |
GV
Geplanter Verkauf
|
CARUSO JAMES V
Chief Commercial Officer
Führungsperson
|
37.500
-26.6%
8,13
304.875 USD
|
37.500
-26.6%
|
8,13
|
304.875 USD
|
|
|
2010-03-03 |
2010-03-01 |
GV
Geplanter Verkauf
|
CARUSO JAMES V
Chief Commercial Officer
Führungsperson
|
40.000
-22.1%
8,13
325.204 USD
|
40.000
-22.1%
|
8,13
|
325.204 USD
|
|
|
2010-02-24 |
2010-02-24 |
GV
Geplanter Verkauf
|
BERNS PAUL L
Chief Executive Officer
Führungsperson
|
7.362
-3.2%
7,57
55.766 USD
|
7.362
-3.2%
|
7,57
|
55.766 USD
|
|
|
2010-02-24 |
2010-02-24 |
GV
Geplanter Verkauf
|
Graboyes Marc H
SVP, General Counsel
Führungsperson
|
2.349
-3.9%
7,44
17.477 USD
|
2.349
-3.9%
|
7,44
|
17.477 USD
|
|
|
2010-02-24 |
2010-02-23 |
GV
Geplanter Verkauf
|
BERNS PAUL L
Chief Executive Officer
Führungsperson
|
4.304
-1.8%
7,51
32.331 USD
|
4.304
-1.8%
|
7,51
|
32.331 USD
|
|
|
2010-02-24 |
2010-02-23 |
GV
Geplanter Verkauf
|
CARUSO JAMES V
Chief Commercial Officer
Führungsperson
|
5.968
-4.1%
7,44
44.378 USD
|
5.968
-4.1%
|
7,44
|
44.378 USD
|
|
|
2010-02-24 |
2010-02-23 |
GV
Geplanter Verkauf
|
Graboyes Marc H
SVP, General Counsel
Führungsperson
|
1.416
-2.3%
7,51
10.634 USD
|
1.416
-2.3%
|
7,51
|
10.634 USD
|
|
|
2010-02-24 |
2010-02-23 |
GV
Geplanter Verkauf
|
BENNETT BRUCE K JR
VP, Pharmaceutical Operations
Führungsperson
|
1.468
-6.0%
7,51
11.025 USD
|
1.468
-6.0%
|
7,51
|
11.025 USD
|
|
|
2010-01-11 |
2010-01-11 |
GV
Geplanter Verkauf
|
HOFFMAN STEPHEN J
Nicht geschäftsführender Verwaltungsratsmitglied
|
45.428
-8.7%
7,30
331.738 USD
|
45.428
-8.7%
|
7,30
|
331.738 USD
|
|
|
2010-01-11 |
2010-01-08 |
GV
Geplanter Verkauf
|
HOFFMAN STEPHEN J
Nicht geschäftsführender Verwaltungsratsmitglied
|
45.429
-8.7%
7,11
322.918 USD
|
45.429
-8.7%
|
7,11
|
322.918 USD
|
|
|
2010-01-11 |
2010-01-07 |
GV
Geplanter Verkauf
|
HOFFMAN STEPHEN J
Nicht geschäftsführender Verwaltungsratsmitglied
|
45.429
-8.7%
6,76
307.114 USD
|
45.429
-8.7%
|
6,76
|
307.114 USD
|
|
|
2010-01-06 |
2010-01-06 |
GV
Geplanter Verkauf
|
HOFFMAN STEPHEN J
Nicht geschäftsführender Verwaltungsratsmitglied
|
45.429
-8.7%
6,78
308.163 USD
|
45.429
-8.7%
|
6,78
|
308.163 USD
|
|
|
2010-01-06 |
2010-01-05 |
GV
Geplanter Verkauf
|
HOFFMAN STEPHEN J
Nicht geschäftsführender Verwaltungsratsmitglied
|
45.428
-8.7%
6,64
301.497 USD
|
45.428
-8.7%
|
6,64
|
301.497 USD
|
|
|
2010-01-06 |
2010-01-04 |
GV
Geplanter Verkauf
|
HOFFMAN STEPHEN J
Nicht geschäftsführender Verwaltungsratsmitglied
|
25.428
-5.1%
6,54
166.220 USD
|
25.428
-5.1%
|
6,54
|
166.220 USD
|
|
|
2009-08-12 |
2009-08-10 |
GV
Geplanter Verkauf
|
CARUSO JAMES V
Chief Commercial Officer
Führungsperson
|
85.400
-49.0%
8,13
694.302 USD
|
85.400
-49.0%
|
8,13
|
694.302 USD
|
|
|
2009-08-12 |
2009-08-10 |
GV
Geplanter Verkauf
|
BERNS PAUL L
Chief Executive Officer
Führungsperson
|
342.000
-59.6%
8,24
2.819.311 USD
|
342.000
-59.6%
|
8,24
|
2.819.311 USD
|
|
|
2009-08-07 |
2009-08-05 |
GV
Geplanter Verkauf
|
BERNS PAUL L
Chief Executive Officer
Führungsperson
|
8.000
-3.3%
8,14
65.150 USD
|
8.000
-3.3%
|
8,14
|
65.150 USD
|
|
|
2009-08-05 |
2009-08-05 |
GV
Geplanter Verkauf
|
CARUSO JAMES V
Chief Commercial Officer
Führungsperson
|
14.600
-14.1%
8,13
118.755 USD
|
14.600
-14.1%
|
8,13
|
118.755 USD
|
|
|
2009-08-05 |
2009-08-03 |
GV
Geplanter Verkauf
|
Graboyes Marc H
VP, General Counsel
Führungsperson
|
50.000
-71.4%
8,00
400.000 USD
|
50.000
-71.4%
|
8,00
|
400.000 USD
|
|
|
2009-08-05 |
2009-08-03 |
GV
Geplanter Verkauf
|
CARUSO JAMES V
Chief Commercial Officer
Führungsperson
|
50.000
-36.0%
7,79
389.480 USD
|
50.000
-36.0%
|
7,79
|
389.480 USD
|
|
|
2009-03-27 |
2009-03-26 |
GV
Geplanter Verkauf
|
CARUSO JAMES V
Chief Commercial Officer
Führungsperson
|
39.500
-25.3%
7,37
291.206 USD
|
39.500
-25.3%
|
7,37
|
291.206 USD
|
|
|
2009-03-27 |
2009-03-25 |
GV
Geplanter Verkauf
|
CARUSO JAMES V
Chief Commercial Officer
Führungsperson
|
6.900
-5.6%
7,13
49.209 USD
|
6.900
-5.6%
|
7,13
|
49.209 USD
|
|
|
2009-03-16 |
2009-03-16 |
GV
Geplanter Verkauf
|
CARUSO JAMES V
Chief Commercial Officer
Führungsperson
|
3.600
-3.0%
7,13
25.674 USD
|
3.600
-3.0%
|
7,13
|
25.674 USD
|
|
|
2009-03-16 |
2009-03-13 |
GV
Geplanter Verkauf
|
Clark David C
VP, Finance
Führungsperson
|
5.027
-41.3%
7,00
35.189 USD
|
5.027
-41.3%
|
7,00
|
35.189 USD
|
|
|
2009-03-16 |
2009-03-13 |
GV
Geplanter Verkauf
|
Graboyes Marc H
VP, General Counsel
Führungsperson
|
5.864
-22.6%
7,00
41.048 USD
|
5.864
-22.6%
|
7,00
|
41.048 USD
|
|
|
2009-03-16 |
2009-03-12 |
GV
Geplanter Verkauf
|
Clark David C
VP, Finance
Führungsperson
|
64.973
-90.1%
7,02
455.812 USD
|
64.973
-90.1%
|
7,02
|
455.812 USD
|
|
|
2009-03-16 |
2009-03-12 |
GV
Geplanter Verkauf
|
CARUSO JAMES V
Chief Commercial Officer
Führungsperson
|
50.000
-30.1%
7,13
356.500 USD
|
50.000
-30.1%
|
7,13
|
356.500 USD
|
|
|
2009-03-16 |
2009-03-12 |
GV
Geplanter Verkauf
|
Graboyes Marc H
VP, General Counsel
Führungsperson
|
69.136
-77.5%
7,02
485.010 USD
|
69.136
-77.5%
|
7,02
|
485.010 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Verkauf
|
14159 capital (GP), LLC
Large shareholder
|
22
-0.0%
8,26
182 USD
|
22
-0.0%
|
8,26
|
182 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Verkauf
|
14159 capital (GP), LLC
Large shareholder
|
24.857
-11.5%
8,17
203.176 USD
|
24.857
-11.5%
|
8,17
|
203.176 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Verkauf
|
BAKER JULIAN
Large shareholder
|
1
-0.0%
8,26
8 USD
|
1
-0.0%
|
8,26
|
8 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Verkauf
|
BAKER JULIAN
Large shareholder
|
705
-11.5%
8,17
5.763 USD
|
705
-11.5%
|
8,17
|
5.763 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Verkauf
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
235
-0.0%
8,26
1.940 USD
|
235
-0.0%
|
8,26
|
1.940 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Verkauf
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
263.312
-11.5%
8,17
2.152.260 USD
|
263.312
-11.5%
|
8,17
|
2.152.260 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Verkauf
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
212
-11.5%
8,17
1.733 USD
|
212
-11.5%
|
8,17
|
1.733 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Verkauf
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
8
-0.0%
8,26
66 USD
|
8
-0.0%
|
8,26
|
66 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Verkauf
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
9.380
-11.5%
8,17
76.670 USD
|
9.380
-11.5%
|
8,17
|
76.670 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Verkauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
670
-0.0%
8,26
5.532 USD
|
670
-0.0%
|
8,26
|
5.532 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Verkauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
751.534
-11.5%
8,17
6.142.889 USD
|
751.534
-11.5%
|
8,17
|
6.142.889 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
14159 capital (GP), LLC
Large shareholder
|
4.725
-2.1%
8,11
38.299 USD
|
4.725
-2.1%
|
8,11
|
38.299 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
14159 capital (GP), LLC
Large shareholder
|
1.200
-0.5%
8,17
9.806 USD
|
1.200
-0.5%
|
8,17
|
9.806 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
14159 capital (GP), LLC
Large shareholder
|
6.392
-2.8%
8,16
52.180 USD
|
6.392
-2.8%
|
8,16
|
52.180 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
BAKER JULIAN
Large shareholder
|
134
-2.1%
8,11
1.086 USD
|
134
-2.1%
|
8,11
|
1.086 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
BAKER JULIAN
Large shareholder
|
34
-0.5%
8,17
278 USD
|
34
-0.5%
|
8,17
|
278 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
BAKER JULIAN
Large shareholder
|
181
-2.8%
8,16
1.478 USD
|
181
-2.8%
|
8,16
|
1.478 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
50.041
-2.1%
8,11
405.617 USD
|
50.041
-2.1%
|
8,11
|
405.617 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
12.713
-0.5%
8,17
103.882 USD
|
12.713
-0.5%
|
8,17
|
103.882 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
67.709
-2.8%
8,16
552.729 USD
|
67.709
-2.8%
|
8,16
|
552.729 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
40
-2.1%
8,11
324 USD
|
40
-2.1%
|
8,11
|
324 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
10
-0.5%
8,17
82 USD
|
10
-0.5%
|
8,17
|
82 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
55
-2.8%
8,16
449 USD
|
55
-2.8%
|
8,16
|
449 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
1.782
-2.1%
8,11
14.444 USD
|
1.782
-2.1%
|
8,11
|
14.444 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
453
-0.5%
8,17
3.702 USD
|
453
-0.5%
|
8,17
|
3.702 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
2.411
-2.8%
8,16
19.682 USD
|
2.411
-2.8%
|
8,16
|
19.682 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
142.827
-2.1%
8,11
1.157.713 USD
|
142.827
-2.1%
|
8,11
|
1.157.713 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
36.286
-0.5%
8,17
296.504 USD
|
36.286
-0.5%
|
8,17
|
296.504 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Verkauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
193.252
-2.8%
8,16
1.577.574 USD
|
193.252
-2.8%
|
8,16
|
1.577.574 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Verkauf
|
14159 capital (GP), LLC
Large shareholder
|
24.256
-9.6%
8,46
205.191 USD
|
24.256
-9.6%
|
8,46
|
205.191 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Verkauf
|
14159 capital (GP), LLC
Large shareholder
|
2.593
-1.0%
8,47
21.961 USD
|
2.593
-1.0%
|
8,47
|
21.961 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Verkauf
|
14159 capital (GP), LLC
Large shareholder
|
269
-0.1%
9,03
2.430 USD
|
269
-0.1%
|
9,03
|
2.430 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Verkauf
|
BAKER JULIAN
Large shareholder
|
688
-9.6%
8,46
5.820 USD
|
688
-9.6%
|
8,46
|
5.820 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Verkauf
|
BAKER JULIAN
Large shareholder
|
74
-1.0%
8,47
627 USD
|
74
-1.0%
|
8,47
|
627 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Verkauf
|
BAKER JULIAN
Large shareholder
|
8
-0.1%
9,03
72 USD
|
8
-0.1%
|
9,03
|
72 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Verkauf
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
256.936
-9.6%
8,46
2.173.524 USD
|
256.936
-9.6%
|
8,46
|
2.173.524 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Verkauf
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
27.485
-1.1%
8,47
232.781 USD
|
27.485
-1.1%
|
8,47
|
232.781 USD
|
|
